|Articles|September 15, 2014
In The Literature: MicroRNA Biomarkers Could Predict Chemotherapy Response in Lung Cancer
MicroRNAs have the potential to be predictive biomarkers that can predict survival as well as response to chemotherapy, as this study discovered.
Advertisement
Tumor samples from recurrent lung adenocarcinoma patients treated with platinum-based doublet chemotherapy were analyzed for microRNA expression. The analysis identified a signature: miR1290, miR196b, and miR135a*. These 3 microRNAs could predict chemotherapy response, not progression-free survival or overall survival, in patients with recurrent lung cancer.
Link to the abstract in Clinical Cancer Research:
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
How Often Do Health Insurers Deny Doctor-Recommended Care?
2
Acoramidis Shows Durable Benefit at 54 Months in ATTR-CM
3
New Data Support Pimicotinib as Durable for Rare Tenosynovial Giant Cell Tumor
4
What Managed Care Should Watch at ADA 2026 Scientific Sessions
5